$TPST
Tempest Therapeutics, Inc.

2013 Q3 Form 10-Q Financial Statement

#000110465913063041 Filed on August 13, 2013

View on sec.gov

Income Statement

Concept 2013 Q3 2013 Q2 2012 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.660M $3.450M $1.780M
YoY Change 139.22% 83.51% 165.67%
% of Gross Profit
Research & Development $3.262M $2.576M $2.430M
YoY Change 104.51% 90.67% 215.58%
% of Gross Profit
Depreciation & Amortization $70.00K $50.00K $40.00K
YoY Change 133.33% 150.0%
% of Gross Profit
Operating Expenses $6.925M $6.021M $4.210M
YoY Change 121.96% 86.18% 192.36%
Operating Profit -$6.925M -$6.021M
YoY Change 121.96% 86.18%
Interest Expense $30.00K $30.00K $20.00K
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$6.890M -$6.000M -$4.190M
YoY Change 120.83% 85.76% 190.97%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$6.891M -$5.996M -$4.190M
YoY Change 121.01% 85.41% 190.97%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$86.12 -$85.71 -$69.83
COMMON SHARES
Basic Shares Outstanding 18.20M shares 18.19M shares 14.26M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q3 2013 Q2 2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $49.60M $54.30M $31.40M
YoY Change 41.31% 59.24% 597.78%
Cash & Equivalents $21.08M $28.19M $14.78M
Short-Term Investments $28.50M $26.20M $16.60M
Other Short-Term Assets $800.0K $900.0K $600.0K
YoY Change 60.0% 350.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $50.41M $55.26M $31.97M
YoY Change 41.68% 61.23% 597.16%
LONG-TERM ASSETS
Property, Plant & Equipment $730.0K $890.0K $756.0K
YoY Change 11.62% 105.07%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $88.00K $88.00K $93.00K
YoY Change -5.38% -70.67%
Total Long-Term Assets $818.0K $978.0K $849.0K
YoY Change 9.5% 35.08%
TOTAL ASSETS
Total Short-Term Assets $50.41M $55.26M $31.97M
Total Long-Term Assets $818.0K $978.0K $849.0K
Total Assets $51.23M $56.24M $32.81M
YoY Change 41.01% 60.69% 615.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $791.0K $216.0K $875.0K
YoY Change -26.01% -64.0% 217.03%
Accrued Expenses $1.365M $1.596M $1.211M
YoY Change 61.54% 33.0% 203.51%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.156M $1.812M $2.086M
YoY Change 12.64% 0.67% 209.04%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $65.00K $15.00K $7.000K
YoY Change -91.95%
Total Long-Term Liabilities $65.00K $15.00K $7.000K
YoY Change -91.95%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.156M $1.812M $2.086M
Total Long-Term Liabilities $65.00K $15.00K $7.000K
Total Liabilities $2.221M $1.827M $2.093M
YoY Change 16.04% 1.5% 174.67%
SHAREHOLDERS EQUITY
Retained Earnings -$34.18M -$27.29M -$16.13M
YoY Change 186.2% 514.86%
Common Stock $17.00K $17.00K $13.00K
YoY Change 21.43% 550.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $49.00M $54.41M $30.72M
YoY Change
Total Liabilities & Shareholders Equity $51.20M $56.24M $32.81M
YoY Change 40.95% 60.69% 615.68%

Cashflow Statement

Concept 2013 Q3 2013 Q2 2012 Q4
OPERATING ACTIVITIES
Net Income -$6.891M -$5.996M -$4.190M
YoY Change 121.01% 85.41% 190.97%
Depreciation, Depletion And Amortization $70.00K $50.00K $40.00K
YoY Change 133.33% 150.0%
Cash From Operating Activities -$4.190M -$5.160M -$3.490M
YoY Change 43.0% 31.63% 232.38%
INVESTING ACTIVITIES
Capital Expenditures $280.0K $50.00K $150.0K
YoY Change 16.67% 66.67%
Acquisitions
YoY Change
Other Investing Activities -$2.490M -$9.780M -$16.70M
YoY Change 10766.67%
Cash From Investing Activities -$2.760M -$9.840M -$16.84M
YoY Change 1004.0% 8100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -160.0K 0.000 -20.00K
YoY Change -103.77% -100.0%
NET CHANGE
Cash From Operating Activities -4.190M -5.160M -3.490M
Cash From Investing Activities -2.760M -9.840M -16.84M
Cash From Financing Activities -160.0K 0.000 -20.00K
Net Change In Cash -7.110M -15.00M -20.35M
YoY Change -770.75% 255.45% 1838.1%
FREE CASH FLOW
Cash From Operating Activities -$4.190M -$5.160M -$3.490M
Capital Expenditures $280.0K $50.00K $150.0K
Free Cash Flow -$4.470M -$5.210M -$3.640M
YoY Change 41.01% 31.9% 246.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q2 us-gaap Operating Expenses
OperatingExpenses
3234000 USD
us-gaap Operating Expenses
OperatingExpenses
11196000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28193000 USD
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
88000 USD
CY2013Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1596000 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1211000 USD
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1812000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
93000 USD
CY2013Q2 us-gaap Assets
Assets
56240000 USD
CY2012Q4 us-gaap Assets
Assets
32814000 USD
dei Entity Registrant Name
EntityRegistrantName
OvaScience, Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0001544227
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
18203156 shares
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2013Q2 us-gaap Short Term Investments
ShortTermInvestments
26152000 USD
CY2012Q4 us-gaap Short Term Investments
ShortTermInvestments
16615000 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
574000 USD
CY2013Q2 us-gaap Assets Current
AssetsCurrent
55262000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
31965000 USD
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
890000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
756000 USD
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
216000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
875000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2086000 USD
CY2013Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
15000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7000 USD
CY2013Q2 us-gaap Liabilities
Liabilities
1827000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
2093000 USD
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
17000 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
13000 USD
CY2013Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
81709000 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
46848000 USD
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-26000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6000 USD
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-27287000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16134000 USD
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
54413000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
30721000 USD
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
56240000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
32814000 USD
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
us-gaap Operating Expenses
OperatingExpenses
6200000 USD
us-gaap Net Income Loss
NetIncomeLoss
-27287000 USD
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18203156 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14268068 shares
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
6021000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6021000 USD
us-gaap Operating Expenses
OperatingExpenses
27349000 USD
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.74
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16887037 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12622919 shares
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2576000 USD
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1351000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5256000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2297000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12749000 USD
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3445000 USD
CY2012Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1883000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5940000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3903000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14600000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-27349000 USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6302000 shares
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
720000 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3234000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-11196000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-6200000 USD
CY2013Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
25000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
43000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
62000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-5996000 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-3234000 USD
us-gaap Net Income Loss
NetIncomeLoss
-11153000 USD
us-gaap Net Income Loss
NetIncomeLoss
-6200000 USD
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
-101000 USD
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5996000 USD
CY2012Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3234000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11153000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6200000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-27388000 USD
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.36
CY2012Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.09
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-4.22
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-4.35
CY2013Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
16869000 shares
CY2012Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1548000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
15132000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1469000 shares
CY2013Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-27000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-20000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-26000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6023000 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3234000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11173000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6200000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-27313000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
100000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
22000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
193000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2211000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
559000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3939000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
338000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
165000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
912000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-659000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
328000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
216000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
393000 USD
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1612000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-9220000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4736000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-21936000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
234000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
456000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1083000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
10783000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
27481000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
93000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4541000 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34067000 USD
CY2013Q2 ovas Cash Resources Sufficient To Fund Current Operating Plan
CashResourcesSufficientToFundCurrentOperatingPlan
54300000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
93000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-10017000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-549000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-27657000 USD
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
34992000 USD
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
41091000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
32654000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 item
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
36695000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
32654000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
34811000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
77786000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
13417000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
29526000 USD
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
28193000 USD
ovas Number Of Geographic Segments
NumberOfGeographicSegments
1 item
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Use of estimates</font></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">These condensed consolidated financial statements are presented in conformity with U.S. generally accepted accounting principles which require management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from such estimates.</font></p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;">&#160;</p> </div>
CY2013Q2 ovas Cash And Money Market Funds Amortized Cost
CashAndMoneyMarketFundsAmortizedCost
28193000 USD
CY2012Q4 ovas Cash And Money Market Funds Amortized Cost
CashAndMoneyMarketFundsAmortizedCost
14776000 USD
CY2013Q2 ovas Cash And Money Market Funds Fair Value
CashAndMoneyMarketFundsFairValue
28193000 USD
CY2012Q4 ovas Cash And Money Market Funds Fair Value
CashAndMoneyMarketFundsFairValue
14776000 USD
CY2013Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
54371000 USD
CY2012Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
31397000 USD
CY2013Q2 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
1000 USD
CY2012Q4 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
5000 USD
CY2013Q2 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
27000 USD
CY2012Q4 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
11000 USD
CY2013Q2 us-gaap Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
54345000 USD
CY2012Q4 us-gaap Available For Sale Securities Fair Value Disclosure
AvailableForSaleSecuritiesFairValueDisclosure
31391000 USD
CY2013Q2 ovas Cash Cash Equivalents And Marketable Securities Amortized Cost
CashCashEquivalentsAndMarketableSecuritiesAmortizedCost
54588000 USD
CY2012Q4 ovas Cash Cash Equivalents And Marketable Securities Amortized Cost
CashCashEquivalentsAndMarketableSecuritiesAmortizedCost
31397000 USD
CY2013Q2 ovas Cash Cash Equivalents And Marketable Securities Fair Value
CashCashEquivalentsAndMarketableSecuritiesFairValue
54561000 USD
CY2012Q4 ovas Cash Cash Equivalents And Marketable Securities Fair Value
CashCashEquivalentsAndMarketableSecuritiesFairValue
31391000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
28193000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
14776000 USD
CY2013Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
14200000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y
us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
1000000 USD
us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
1000000 USD
CY2013Q2 ovas Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Number Of Securities
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsNumberOfSecurities
21 item
CY2013Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
20200000 USD
CY2013Q2 ovas Fair Value Assets Level1 To Level2 Transfer Amount
FairValueAssetsLevel1ToLevel2TransferAmount
0 USD
ovas Fair Value Assets Level1 To Level2 Transfer Amount
FairValueAssetsLevel1ToLevel2TransferAmount
0 USD
CY2013Q2 ovas Fair Value Assets Level2 To Level1 Transfer Amount
FairValueAssetsLevel2ToLevel1TransferAmount
0 USD
ovas Fair Value Assets Level2 To Level1 Transfer Amount
FairValueAssetsLevel2ToLevel1TransferAmount
0 USD
CY2013Q2 ovas Fair Value Liabilities Level1 To Level2 Transfer Amount
FairValueLiabilitiesLevel1ToLevel2TransferAmount
0 USD
ovas Fair Value Liabilities Level1 To Level2 Transfer Amount
FairValueLiabilitiesLevel1ToLevel2TransferAmount
0 USD
CY2013Q2 ovas Fair Value Liabilities Level2 To Level1 Transfer Amount
FairValueLiabilitiesLevel2ToLevel1TransferAmount
0 USD
ovas Fair Value Liabilities Level2 To Level1 Transfer Amount
FairValueLiabilitiesLevel2ToLevel1TransferAmount
0 USD
CY2013Q2 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0 USD
CY2012Q2 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0 USD
us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0 USD
us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
226000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
303000 USD
ovas Development Stage Enterprise Product Revenues
DevelopmentStageEnterpriseProductRevenues
0 USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
41192000 USD
ovas Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Number Of Securities
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerNumberOfSecurities
0 item
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
182000 USD

Files In Submission

Name View Source Status
0001104659-13-063041-index-headers.html Edgar Link pending
0001104659-13-063041-index.html Edgar Link pending
0001104659-13-063041.txt Edgar Link pending
0001104659-13-063041-xbrl.zip Edgar Link pending
a13-13628_110q.htm Edgar Link pending
a13-13628_1ex31d1.htm Edgar Link pending
a13-13628_1ex31d2.htm Edgar Link pending
a13-13628_1ex32d1.htm Edgar Link pending
a13-13628_1ex32d2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
ovas-20130630.xml Edgar Link completed
ovas-20130630.xsd Edgar Link pending
ovas-20130630_cal.xml Edgar Link unprocessable
ovas-20130630_def.xml Edgar Link unprocessable
ovas-20130630_lab.xml Edgar Link unprocessable
ovas-20130630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending